Optipharm.CO.LTD (153710) — Cash Flow Reinvestment Rate
Optipharm.CO.LTD (153710) has a Cash Flow Reinvestment Rate of 1.56x as of September 2025, reinvesting ₩493.26 Million (capex ₩97.26 Million plus investments ₩396.00 Million) from operating cash flow of ₩315.25 Million. Explore Optipharm.CO.LTD capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Optipharm.CO.LTD Cash Flow Reinvestment Rate (2016–2019)
Historical reinvestment intensity for Optipharm.CO.LTD across 4 annual periods. Also explore 153710 total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Optipharm.CO.LTD (2016–2019)
Year-by-year capital reinvestment analysis for Optipharm.CO.LTD. For live market cap and broader valuation context, see Optipharm.CO.LTD stock valuation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 13.02x | ₩5.83 Billion | ₩447.47 Million | ₩626.46 Million | ▲ +6121.0% |
| 2018 | 0.21x | ₩251.91 Million | ₩1.20 Billion | ₩202.91 Million | ▼ -92.4% |
| 2017 | 2.77x | ₩722.33 Million | ₩260.86 Million | ₩670.33 Million | ▲ +473.4% |
| 2016 | 0.48x | ₩415.95 Million | ₩861.36 Million | ₩391.95 Million | — |